438 related articles for article (PubMed ID: 16712664)
1. Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.
Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
Clin Endocrinol (Oxf); 2006 Jun; 64(6):632-9. PubMed ID: 16712664
[TBL] [Abstract][Full Text] [Related]
2. Elevation of E-selectin concentrations may correlate with potential endothelial dysfunction in individuals with hypopituitarism during therapy with growth hormone.
Gómez JM; Sahún M; Vila R; Domènech P; Catalina P; Soler J; Badimón L
Curr Neurovasc Res; 2007 Feb; 4(1):55-62. PubMed ID: 17311545
[TBL] [Abstract][Full Text] [Related]
3. Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk.
Abdu TA; Elhadd TA; Buch H; Barton D; Neary R; Clayton RN
Clin Endocrinol (Oxf); 2004 Sep; 61(3):387-93. PubMed ID: 15355457
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency.
Elhadd TA; Abdu TA; Oxtoby J; Kennedy G; McLaren M; Neary R; Belch JJ; Clayton RN
J Clin Endocrinol Metab; 2001 Sep; 86(9):4223-32. PubMed ID: 11549653
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
Evans LM; Davies JS; Goodfellow J; Rees JA; Scanlon MF
Clin Endocrinol (Oxf); 1999 Apr; 50(4):457-64. PubMed ID: 10468904
[TBL] [Abstract][Full Text] [Related]
6. Effects of GH treatment in GH-deficient adults on adiponectin, leptin and pregnancy-associated plasma protein-A.
Joaquin C; Aguilera E; Granada ML; Pastor MC; Salinas I; Alonso N; Sanmartí A
Eur J Endocrinol; 2008 Apr; 158(4):483-90. PubMed ID: 18362295
[TBL] [Abstract][Full Text] [Related]
7. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency.
Evans LM; Davies JS; Anderson RA; Ellis GR; Jackson SK; Lewis MJ; Frenneaux MP; Rees A; Scanlon MF
Eur J Endocrinol; 2000 Mar; 142(3):254-62. PubMed ID: 10700719
[TBL] [Abstract][Full Text] [Related]
8. Effects of 7 years of growth hormone replacement therapy in hypopituitary adults.
Chrisoulidou A; Beshyah SA; Rutherford O; Spinks TJ; Mayet J; Kyd P; Anyaoku V; Haida A; Ariff B; Murphy M; Thomas E; Robinson S; Foale R; Johnston DG
J Clin Endocrinol Metab; 2000 Oct; 85(10):3762-9. PubMed ID: 11061536
[TBL] [Abstract][Full Text] [Related]
9. Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement.
Kvasnicka J; Marek J; Kvasnicka T; Weiss V; Marková M; Stĕpán J; Umlaufová A
Clin Endocrinol (Oxf); 2000 May; 52(5):543-8. PubMed ID: 10792332
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of high-sensitivity C-reactive protein and soluble markers of vascular endothelial cell activation in growth hormone-deficient adolescents.
Lanes R; Marcano H; Villaroel O; Gunczler P; Morillo E; Paoli M; Perez M; Maulino N; Palacios A
Horm Res; 2008; 70(4):230-5. PubMed ID: 18772596
[TBL] [Abstract][Full Text] [Related]
11. Coronary flow reserve is impaired in patients with adult growth hormone (GH) deficiency.
Oflaz H; Sen F; Elitok A; Cimen AO; Onur I; Kasikcioglu E; Korkmaz S; Demirturk M; Kutluturk F; Pamukcu B; Ozbey N
Clin Endocrinol (Oxf); 2007 Apr; 66(4):524-9. PubMed ID: 17371470
[TBL] [Abstract][Full Text] [Related]
12. Baseline characteristics and effects of growth hormone therapy over two years in younger and elderly adults with adult onset GH deficiency.
Franco C; Johannsson G; Bengtsson BA; Svensson J
J Clin Endocrinol Metab; 2006 Nov; 91(11):4408-14. PubMed ID: 16940452
[TBL] [Abstract][Full Text] [Related]
13. Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.
Smith JC; Evans LM; Wilkinson I; Goodfellow J; Cockcroft JR; Scanlon MF; Davies JS
Clin Endocrinol (Oxf); 2002 Apr; 56(4):493-501. PubMed ID: 11966742
[TBL] [Abstract][Full Text] [Related]
14. Intima-media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors.
Leonsson M; Hulthe J; Oscarsson J; Johannsson G; Wendelhag I; Wikstrand J; Bengtsson BA
Clin Endocrinol (Oxf); 2002 Dec; 57(6):751-9. PubMed ID: 12460325
[TBL] [Abstract][Full Text] [Related]
15. Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiency.
Maccario M; Aimaretti G; Grottoli S; Gauna C; Tassone F; Corneli G; Rossetto R; Wu Z; Strasburger CJ; Ghigo E
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1233-9. PubMed ID: 11477509
[TBL] [Abstract][Full Text] [Related]
16. Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency.
Colao A; Di Somma C; Cuocolo A; Spinelli L; Acampa W; Spiezia S; Rota F; Savanelli MC; Lombardi G
J Clin Endocrinol Metab; 2005 Sep; 90(9):5146-55. PubMed ID: 15985481
[TBL] [Abstract][Full Text] [Related]
17. Insulin sensitivity is impaired in adults with varying degrees of GH deficiency.
Murray RD; Shalet SM
Clin Endocrinol (Oxf); 2005 Feb; 62(2):182-8. PubMed ID: 15670194
[TBL] [Abstract][Full Text] [Related]
18. Growth hormone replacement normalizes impaired fibrinolysis: new insights into endothelial dysfunction in patients with hypopituitarism and growth hormone deficiency.
Miljic D; Miljic P; Doknic M; Pekic S; Stojanovic M; Cvijovic G; Micic D; Popovic V
Growth Horm IGF Res; 2013 Dec; 23(6):243-8. PubMed ID: 24041757
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency.
Colao A; Di Somma C; Filippella M; Rota F; Pivonello R; Orio F; Vitale G; Lombardi G
Clin Endocrinol (Oxf); 2004 Sep; 61(3):360-6. PubMed ID: 15355453
[TBL] [Abstract][Full Text] [Related]
20. Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency.
Benedini S; Dalle Carbonare L; Albiger N; Scanarini M; Bilora F; Petrobelli F; Giannini S; Mantero F; Scaroni C
Horm Metab Res; 2006 Jan; 38(1):16-21. PubMed ID: 16477535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
